| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0054 | 0.9 |